Autoantibody to alanyl-tRNA synthetase in patients with idiopathic pulmonary fibrosis

Respirology

Volumn 12, Issue 5, 2007, Pages 642-653

  Takahashi, Toru ^a   Wada, Ikuo ^b   Ohtsuka, Yoshinori ^c   Munakata, Mitsuru ^c   Homma, Yukihiko ^d   Kuroki, Yoshio ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Institute of Biomedical Sciences   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Alanyl tRNA synthetase; Autoantibody; Autoimmunity; Lung; Molecular biology

Indexed keywords

ALANINE TRANSFER RNA LIGASE; AUTOANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; LUNG ALVEOLUS CELL TYPE 2; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TANDEM MASS SPECTROMETRY;

ALANINE-TRNA LIGASE; AUTOANTIBODIES; AUTOIMMUNITY; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PULMONARY FIBROSIS; TRANSFECTION;

EID: 34548693221     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01140.x     Document Type: Article

References (56)

1. Coultas DB, Zumwalt BR, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am. Rev. Respir. Dis. 1994 150 : 967 72.
2. Baumgartner KB, Samet LM, Stidley CA, Colby TV, Waldron JA, Collaborating Centers. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1997 155 : 242 8.
3. Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996 347 : 284 9.
4. Kuwano K, Nomoto Y, Kunitake R, Hagimoto N, Matsuba T et al. Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur. Respir. J. 1997 10 : 1445 9.
5. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB et al. Epstein-Barr virus replication within pulmonaryepithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995 50 : 1234 9.
6. Ueda T, Ohta K, Suzuki N, Yamaguchi M, Hirai K et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am. Rev. Respir. Dis. 1992 146 : 266 8.
7. Elias JA, Jimenez SA, Freundlich B. Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. Am. Rev. Respir. Dis. 1987 135 : 62 5.
8. Lynch JP Standiford TJ, Rolfe MW, Kunkel SL, Strieter RM. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1992 145 : 1433 9.
9. Carré PC, Mortenson RL, King TE Jr, Noble PW, Sable CL et al. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J. Clin. Invest. 1991 88 : 1802 10.
10. Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis. Ann. Int. Med. 1976 85 : 769 88.
11. Fraire AE, Greenberg SD, O'Neal RM, Weg JG, Jenkins DE. Diffuse interstitial fibrosis of the lung. Am. J. Clin. Pathol. 1973 59 : 636 47.
12. Hodson ME, Haslam PL, Spiro SG, Turner-Warwick M. Digital vasculitis in patients with cryptogenic fibrosing alveolitis. Br. J. Dis. Chest 1984 78 : 140 8.
13. Scadding JG, Hinson KF. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lung). Correlation of histology at biopsy with prognosis. Thorax 1967 22 : 291 304.
14. Campbell EJ, Harris B, Avioli LV. Idiopathic pulmonary fibrosis. Arch. Intern. Med. 1981 141 : 771 4.
15. Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR et al. Interstitial lung disease: current concept of pathogenesis, staging and therapy. Am. J. Med. 1981 70 : 542 68.
16. Nagaya H, Sieker HO. Pathogenetic mechanisms of interstitial pulmonary fibrosis in patients with serum antinuclear factor. A histologic and clinical correlation. Am. J. Med. 1972 52 : 51 62.
17. Turner-Warwick M, Haslam P, Weeks J. Antibodies in some chronic fibrosing lung diseases. II. Immunofluorescent studies. Clin. Allergy 1971 1 : 209 19.
18. Chapman JR, Charles PJ, Venables PJ, Thompson PJ, Haslam PL et al. Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis. Am. Rev. Respir. Dis. 1984 130 : 439 43.
19. Haslam P, Turner-Warwick M, Lukoszek A. Antinuclear antibody and lymphocyte responses to nuclear antigens in patients with lung disease. Clin. Exp. Immunol. 1975 20 : 379 95.
20. Dreisin RB, Schwarz MI, Theofilopoulos AN, Stanford RE. Circulating immune complexes in the idiopathic interstitial pneumonias. N. Engl. J. Med. 1978 298 : 353 7.
21. Gottlieb AJ, Spiera H, Teirstein AS, Siltzbach LE. Serologic factors in idiopathic diffuse interstitial pulmonary fibrosis. Am. J. Med. 1965 39 : 405 10.
22. Haslam PL, Thompson B, Mohammed I, Townsend PJ, Hodson ME et al. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin. Exp. Immunol. 1979 37 : 381 90.
23. Daniele RP, Henson PM, Fantone JC Ward PA, Dreisin RB. Immune complex injury of the lung. Am. Rev. Respir. Dis. 1981 124 : 738 55.
24. Schwarz MI, Dreisin RB, Pratt DS, Stanford RE. Immunofluorescent patterns in the idiopathic interstitial pneumonias. J. Lab. Clin. Med. 1978 91 : 929 38.
25. Eisenberg H, Barnett E, Simmons H. Diffuse pulmonary interstitial disease, an immune complex disease (Abstract). Clin. Res. 1977 25 : A132.
26. Jansen HM, Schutte AJH, Elema JD, Giessen MV, Reig RP et al. Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases. Clin. Exp. Immunol. 1984 56 : 311 20.
27. Kallenberg CG, Schilizzi BM, Beaumont F, Poppema S, De Leij L et al. Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis. Clin. Exp. Immunol. 1987 67 : 182 90.
28. Jennings L, Roholt OA, Pressman D, Blau M, Andres GA et al. Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. J. Immunol. 1981 127 : 129 34.
29. Baumgartner U, Scholmerich J, Becher S, Costabel U. Detection of antibodies in serum of patients with idiopathic pulmonary fibrosis against isolated rat alveolar type II cells. Respiration 1987 52 : 122 8.
30. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR et al. Idiopathic pulmonary fibrosis - clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann. Intern. Med. 1976 85 : 769 88.
31. Watters LC, Schwarz MI, Cherniack RM, Waldron JA, Dunn TL et al. Idiopathic pulmonary fibrosis - pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am. Rev. Respir. Dis. 1987 135 : 696 704.
32. Wallace WA, Schofield JA, Lamb D, Howie SE. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 1994 49 : 1139 45.
33. Wallace WA, Roberts SN, Caldwell H, Thornton E, Greening AP et al. Circulating antibodies to lung protein (s) in patients with cryptogenic fibrosing alveolitis. Thorax 1994 49 : 218 22.
34. Gelpi C, Martinez MA, Vidal S, Targoff IN, Rodriguez-Sanchez JL. Autoantibodies to a transfer RNA-associated protein in a murine model of chronic graft versus host disease. J. Immunol. 1994 152 : 1989 99.
35. King TE Jr. Idiopathic pulmonary fibrosis. In : Schwarz MI, King TE Jr (eds) Interstitial Lung Disease, 3rd edn. BC Decker, Hamilton, 1998 597 644.
36. Baldwin EF, Cournand A, Richards DE Jr. Pulmonary insufficiency: I. Physiological classification, clinical methods of analysis, standard values in normal subjects. Medicine 1948 27 : 243 78.
37. Burrows B, Kask JE, Niden AH, Barclay WR. Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am. Rev. Respir. Dis. 1961 84 : 789.
38. Jakab GJ. Sequential virus infections, bacterial superinfections, and fibrogenesis. Am. Rev. Respir. Dis. 1990 142 : 374 9.
39. Sambrook J. Amplification using CHO cell expression vectors. In : Sambrook J, Fritsch EF, Maniatis T (eds) Current Protocols in Molecular Biology, 2nd edn. Cold Spring Harbor Laboratory Press, New York, 1989 16.14.1.
40. Targoff IN, Arnett FC, Reichlin M. Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum 1988 31 : 515 24.
41. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983 304 : 177 9.
42. Reichlin M, Arnett FC Jr. Multiplicity of antibodies in myositis sera. Arthritis Rheum 1984 27 : 1150 6.
43. Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB et al. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br. Med. J. 1984 289 : 151 2.
44. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S et al. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983 26 : 604 11.
45. Targoff IN, Arnett FC. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am. J. Med. 1990 88 : 241 51.
46. Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP et al. Anti KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J. Immunol. 1999 162 : 2315 20.
47. Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J. Exp. Med. 1986 163 : 1281 91.
48. Keene JD. RNA surfaces as functional mimetics of proteins. Chem. Biol. 1996 3 : 505 13.
49. Hou YM, Schimmel P. A simple structural feature is a major determinant of the identity of a transfer RNA. Nature 1988 333 : 140 5.
50. Park SJ, Schimmel P. Evidence for interaction of an aminoacyl transfer RNA synthetase with a region important for the identity of its cognate transfer RNA. J. Biol. Chem. 1988 263 : 16527 30.
51. Shiba K, Ripmaster T, Suzuki N, Nichols R, Plotz P et al. Human alanyl-tRNA synthetase: conservation in evolution of catalytic core and microhelix recognition. Biochemistry 1995 34 : 10340 9.
52. Ripmaster TL, Shiba K, Schimmel P. Wide cross-species aminoacyl-tRNA synthetase replacement in vivo: yeast cytoplasmic alanine enzyme replaced by human polymyositis serum antigen. Proc. Natl. Acad. Sci. USA 1995 92 : 4932 6.
53. Florentz C, Briand JP, Giege R. Possible functional role of viral tRNA-like structures. FEBS Lett. 1984 176 : 295 300.
54. Walker EJ, Jeffrey PD. Polymyositis and molecular mimicry, a mechanism of autoimmunity. Lancet 1986 2 : 605 7.
55. Homma Y, Ohtsuka Y, Tanimura K, Kusaka H, Munakata M et al. Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? Respiration 1995 62 : 248 51.
56. Lomeo RM, Cornella RJ, Schabel SI, Silver RM. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis. Am. J. Med. 1989 87 : 525 7.